Literature DB >> 24536010

Arm lymphoedema after axillary surgery in women with invasive breast cancer.

H Sackey1, A Magnuson, K Sandelin, G Liljegren, L Bergkvist, Z Fülep, F Celebioglu, J Frisell.   

Abstract

BACKGROUND: The primary aim was to compare arm lymphoedema after sentinel lymph node biopsy (SLNB) alone versus axillary lymph node dissection (ALND) in women with node-negative and node-positive breast cancer. The secondary aim was to examine the potential association between self-reported and objectively measured arm lymphoedema.
METHODS: Women who had surgery during 1999-2004 for invasive breast cancer in four centres in Sweden were included. The study groups were defined by the axillary procedure performed and the presence of axillary metastases: SLNB alone, ALND without axillary metastases, and ALND with axillary metastases. Before surgery, and 1, 2 and 3 years after operation, arm volume was measured and a questionnaire regarding symptoms of arm lymphoedema was completed. A mixed model was used to determine the adjusted mean difference in arm volume between the study groups, and generalized estimating equations were employed to determine differences in self-reported arm lymphoedema.
RESULTS: One hundred and forty women had SLNB alone, 125 had node-negative ALND and 155 node-positive ALND. Women who underwent SLNB had no increase in postoperative arm volume over time, whereas both ALND groups showed a significant increase. The risk of self-reported arm lymphoedema 1, 2 and 3 years after surgery was significantly lower in the SLNB group compared with that in both ALND groups. Three years after surgery there was a significant association between increased arm volume and self-reported symptoms of arm lymphoedema.
CONCLUSION: SLNB is associated with a minimal risk of increased arm volume and few symptoms of arm lymphoedema, significantly less than after ALND, regardless of lymph node status.
© 2014 BJS Society Ltd. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24536010     DOI: 10.1002/bjs.9401

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  16 in total

1.  Stability of the 13-item sense of coherence (SOC) scale: a longitudinal prospective study in women treated for breast cancer.

Authors:  Carina Lindblad; Kerstin Sandelin; Lena-Marie Petersson; Camelia Rohani; Ann Langius-Eklöf
Journal:  Qual Life Res       Date:  2015-08-29       Impact factor: 4.147

Review 2.  The Adventure of Axillary Treatment in Early Stage Breast Cancer.

Authors:  Bekir Kuru
Journal:  Eur J Breast Health       Date:  2020-01-01

Review 3.  Recent progress in the treatment and prevention of cancer-related lymphedema.

Authors:  Simona F Shaitelman; Kate D Cromwell; John C Rasmussen; Nicole L Stout; Jane M Armer; Bonnie B Lasinski; Janice N Cormier
Journal:  CA Cancer J Clin       Date:  2014-11-19       Impact factor: 508.702

4.  The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer.

Authors:  Lisa Rydén; Ida Skarping; Kristoffer Nilsson; Looket Dihge; Adam Fridhammar; Mattias Ohlsson; Linnea Huss; Pär-Ola Bendahl; Katarina Steen Carlsson
Journal:  Breast Cancer Res Treat       Date:  2022-07-05       Impact factor: 4.624

5.  Lymphatic mapping and preoperative imaging in the management of post-mastectomy lymphoedema.

Authors:  Muhammed Chowdhry; Warren Matthew Rozen; Matthew Griffiths
Journal:  Gland Surg       Date:  2016-04

6.  Validation of a nomogram for predicting the risk of lymphedema following contemporary treatment for breast cancer: a large multi-institutional study (KROG 20-05).

Authors:  Hwa Kyung Byun; Jae Sik Kim; Jee Suk Chang; Yeona Cho; Sung-Ja Ahn; Jung Han Yoon; Haeyoung Kim; Nalee Kim; Euncheol Choi; Hyeli Park; Kyubo Kim; Shin-Hyung Park; Chai Hong Rim; Hoon Sik Choi; Yoon Kyeong Oh; Ik Jae Lee; Kyung Hwan Shin; Yong Bae Kim
Journal:  Breast Cancer Res Treat       Date:  2022-02-02       Impact factor: 4.872

7.  Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer.

Authors:  San-Gang Wu; Jia-Yuan Sun; Juan Zhou; Feng-Yan Li; Qin Lin; Huan-Xin Lin; Xun-Xing Guan; Zhen-Yu He
Journal:  BMC Cancer       Date:  2015-02-07       Impact factor: 4.430

8.  Number of negative lymph nodes can predict survival after postmastectomy radiotherapy according to different breast cancer subtypes.

Authors:  San-Gang Wu; Fang Peng; Juan Zhou; Jia-Yuan Sun; Feng-Yan Li; Qin Lin; Huan-Xin Lin; Yong Bao; Zhen-Yu He
Journal:  J Cancer       Date:  2015-01-20       Impact factor: 4.207

9.  Tailoring Pelvic Lymphadenectomy for Patients with Stage IA2, IB1, and IIA1 Uterine Cervical Cancer.

Authors:  Juan Zhou; Jing Ran; Zhen-Yu He; Song Quan; Qiong-Hua Chen; San-Gang Wu; Jia-Yuan Sun
Journal:  J Cancer       Date:  2015-02-25       Impact factor: 4.207

10.  Breast Cancer Subtype is Associated With Axillary Lymph Node Metastasis: A Retrospective Cohort Study.

Authors:  Zhen-Yu He; San-Gang Wu; Qi Yang; Jia-Yuan Sun; Feng-Yan Li; Qin Lin; Huan-Xin Lin
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.